Author:
Woods Beth,Rothery Claire,Anderson Sarah-Jane,Eaton Jeffrey W,Revill Paul,Hallett Timothy B,Claxton Karl
Abstract
IntroductionThe generation of robust evidence has been emphasised as a priority for global health. Evidence generation spans a wide range of activities including clinical trials, surveillance programmes and health system performance measurement. As resources for healthcare and research are limited, the desirability of research expenditure should be assessed on the same basis as other healthcare resources, that is, the health gains from research must be expected to exceed the health opportunity costs imposed as funds are diverted to research rather than service provision.MethodsWe developed a transmission and costing model to examine the impact of generating additional evidence to reduce uncertainties on the evolution of a generalised HIV epidemic in Zambia.ResultsWe demonstrate three important points. First, we can quantify the value of additional evidence in terms of the health gain it is expected to generate. Second, we can quantify the health opportunity cost imposed by research expenditure. Third, the value of evidence generation depends on the budgetary policies in place for managing HIV resources under uncertainty. Generating evidence to reduce uncertainty is particularly valuable when decision makers are required to strictly adhere to expenditure plans and when transfers of funds across geographies/programmes are restricted.ConclusionBetter evidence can lead to health improvements in the same way as direct delivery of healthcare. Quantitative appraisals of evidence generation activities are important and should reflect the impact of improved evidence on population health, evidence generation costs and budgetary policies in place.
Funder
Bill and Melinda Gates Foundation
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference31 articles.
1. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013;Murray;The Lancet,2014
2. World Health Organization . Global update on HIV treatment 2013: results, impact and opportunities 2013.
3. Response to the AIDS Pandemic — A Global Health Model
4. HIV/AIDS JUNPo . A new investment framework for the global HIV response. Geneva: UNAIDS, 2011.
5. HIV/AIDS JUNPo . On the Fast-Track to end AIDS by 2030: Focus on location and population 2015.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献